{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:08:16Z","timestamp":1775192896791,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T00:00:00Z","timestamp":1647216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12185-022-03323-x","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T07:02:35Z","timestamp":1647241355000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Feasibility of ovarian stimulation for fertility preservation during and after blinatumomab treatment for Ph-negative B-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"116","author":[{"given":"Yusuke","family":"Tashiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Iemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masumi","family":"Sunada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"issue":"5","key":"3323_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363\u201385.","journal-title":"CA Cancer J Clin"},{"issue":"23","key":"3323_CR2","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1200\/JCO.2007.10.8993","volume":"25","author":"C Hammond","year":"2007","unstructured":"Hammond C, Abrams JR, Syrjala KL. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol. 2007;25(23):3511\u20137.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3323_CR3","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1046\/j.1365-2141.2000.02053.x","volume":"110","author":"S Chiodi","year":"2000","unstructured":"Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000;110(3):614\u20139.","journal-title":"Br J Haematol"},{"issue":"7","key":"3323_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1231::AID-CNCR18>3.0.CO;2-Y","volume":"86","author":"M Watson","year":"1999","unstructured":"Watson M, Wheatley K, Harrison GA, Zittoun R, Gray RG, Goldstone AH, et al. Severe adverse impact on sexual functioning and fertility of bone marrow transplantation, either allogeneic or autologous, compared with consolidation chemotherapy alone: analysis of the MRC AML 10 trial. Cancer. 1999;86(7):1231\u20139.","journal-title":"Cancer"},{"issue":"11","key":"3323_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/sj.bmt.1705364","volume":"37","author":"A Carter","year":"2006","unstructured":"Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS, et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant. 2006;37(11):1023\u20139.","journal-title":"Bone Marrow Transplant"},{"key":"3323_CR6","first-page":"956190","volume":"2012","author":"BV Rossi","year":"2012","unstructured":"Rossi BV, Missmer S, Correia KF, Wadleigh M, Ginsburg ES. Ovarian reserve in women treated for acute lymphocytic leukemia or acute myeloid leukemia with chemotherapy but not stem cell transplantation. ISRN Oncol. 2012;2012:956190.","journal-title":"ISRN Oncol"},{"issue":"10","key":"3323_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10815-015-0575-2","volume":"32","author":"JL Chan","year":"2015","unstructured":"Chan JL, Johnson LN, Efymow BL, Sammel MD, Gracia CR. Outcomes of ovarian stimulation after treatment with chemotherapy. J Assist Reprod Genet. 2015;32(10):1537\u201345.","journal-title":"J Assist Reprod Genet"},{"issue":"16","key":"3323_CR8","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","volume":"27","author":"DM Green","year":"2009","unstructured":"Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677\u201385.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3323_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.fertnstert.2011.10.040","volume":"97","author":"CR Gracia","year":"2012","unstructured":"Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril. 2012;97(1):134\u201340.","journal-title":"Fertil Steril"},{"issue":"2","key":"3323_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/REP-12-0121","volume":"144","author":"I Ben-Aharon","year":"2012","unstructured":"Ben-Aharon I, Shalgi R. What lies behind chemotherapy-induced ovarian toxicity? Reproduction. 2012;144(2):153\u201363.","journal-title":"Reproduction"},{"issue":"9","key":"3323_CR11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.yexcr.2011.03.010","volume":"317","author":"D Nagorsen","year":"2011","unstructured":"Nagorsen D, Baeuerle PA. Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab. Exp Cell Res. 2011;317(9):1255\u201360.","journal-title":"Exp Cell Res"},{"issue":"4","key":"3323_CR12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00277-019-03854-0","volume":"99","author":"A Apel","year":"2020","unstructured":"Apel A, Ofran Y, Wolach O, Shimony S, Ram R, Levi I, et al. Safety and efficacy of blinatumomab: a real world data. Ann Hematol. 2020;99(4):835\u20138.","journal-title":"Ann Hematol"},{"issue":"1","key":"3323_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00277-018-3495-2","volume":"98","author":"SH Jung","year":"2019","unstructured":"Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, et al. Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed\/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party. Ann Hematol. 2019;98(1):151\u20138.","journal-title":"Ann Hematol"},{"issue":"9","key":"3323_CR14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa1609783","volume":"376","author":"H Kantarjian","year":"2017","unstructured":"Kantarjian H, Stein A, G\u00f6kbuget N, Fielding AK, Schuh AC, Ribera JM, et al. Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med. 2017;376(9):836\u201347.","journal-title":"N Engl J Med"},{"key":"3323_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bpobgyn.2020.06.011","volume":"70","author":"MM Dolmans","year":"2021","unstructured":"Dolmans MM, Donnez J. Fertility preservation in women for medical and social reasons: oocytes vs ovarian tissue. Best Pract Res Clin Obstet Gynaecol. 2021;70:63\u201380.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"3323_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/annonc\/mdz284","volume":"30","author":"M Salama","year":"2019","unstructured":"Salama M, Anazodo A, Woodruff TK. Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach. Ann Oncol. 2019;30(11):1760\u201375.","journal-title":"Ann Oncol"},{"issue":"19","key":"3323_CR17","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994\u20132001.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3323_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.fertnstert.2009.11.032","volume":"94","author":"M Rosendahl","year":"2010","unstructured":"Rosendahl M, Andersen MT, Ralfki\u00e6r E, Kjeldsen L, Andersen MK, Andersen CY. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril. 2010;94(6):2186\u201390.","journal-title":"Fertil Steril"},{"issue":"6","key":"3323_CR19","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.fertnstert.2013.03.027","volume":"99","author":"MM Dolmans","year":"2013","unstructured":"Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril. 2013;99(6):1514\u201322.","journal-title":"Fertil Steril"},{"issue":"3","key":"3323_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/humupd\/dmh021","volume":"10","author":"M Sonmezer","year":"2004","unstructured":"Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10(3):251\u201366.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"3323_CR21","doi-asserted-by":"publisher","first-page":"F15","DOI":"10.1530\/REP-18-0536","volume":"158","author":"MM Dolmans","year":"2019","unstructured":"Dolmans MM, Amorim CA. Fertility preservation: construction and use of artificial ovaries. Reproduction. 2019;158(5):F15\u201325.","journal-title":"Reproduction"},{"key":"3323_CR22","doi-asserted-by":"crossref","first-page":"117955811987016","DOI":"10.1177\/1179558119870163","volume":"13","author":"Z Blumenfeld","year":"2019","unstructured":"Blumenfeld Z. Fertility preservation using GnRH agonists: Rationale, possible mechanisms, and explanation of controversy. Clin Med Insights Reprod Health. 2019;13:1179558119870163.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"6","key":"3323_CR23","doi-asserted-by":"publisher","first-page":"2125.e9","DOI":"10.1016\/j.fertnstert.2011.01.030","volume":"95","author":"M S\u00f6nmezer","year":"2011","unstructured":"S\u00f6nmezer M, T\u00fcrk\u00e7\u00fco\u011flu I, Co\u015fkun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.e9-11.","journal-title":"Fertil Steril"},{"issue":"1","key":"3323_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470-2045(14)71170-2","volume":"16","author":"MS Topp","year":"2015","unstructured":"Topp MS, G\u00f6kbuget N, Stein AS, Zugmaier G, O\u2019Brien S, Bargou RC, et al. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2015;16(1):57\u201366.","journal-title":"Lancet Oncol"},{"issue":"7","key":"3323_CR25","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","volume":"87","author":"JE Sanders","year":"1996","unstructured":"Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87(7):3045\u201352.","journal-title":"Blood"},{"issue":"185","key":"3323_CR26","doi-asserted-by":"publisher","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","volume":"5","author":"L Kalich-Philosoph","year":"2013","unstructured":"Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, et al. Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3323_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/6.1.1","volume":"6","author":"O Bukulmez","year":"2000","unstructured":"Bukulmez O, Arici A. Leukocytes in ovarian function. Hum Reprod Update. 2000;6(1):1\u201315.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3323_CR28","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S0015-0282(16)56581-9","volume":"61","author":"M Brannstrom","year":"1994","unstructured":"Brannstrom M, Pascoe V, Norman RJ, McClure N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil Steril. 1994;61(3):488\u201395.","journal-title":"Fertil Steril"},{"issue":"3","key":"3323_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1212\/NXI.0000000000000453","volume":"5","author":"G Das","year":"2018","unstructured":"Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, et al. Rituximab before and during pregnancy: a systematic review, and a case series in MS and NMOSD. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):453.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"3323_CR30","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/rmb2.12055","volume":"16","author":"Y Asada","year":"2017","unstructured":"Asada Y, Morimoto Y, Nakaoka Y, Yamasaki T, Suehiro Y, Sugimoto H, et al. Age-specific serum anti-M\u00fcllerian hormone concentration in Japanese women and its usefulness as a predictor of the ovarian response. Reprod Med Biol. 2017;16(4):364\u201373.","journal-title":"Reprod Med Biol"},{"issue":"3","key":"3323_CR31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/humrep\/dem392","volume":"23","author":"S Lie Fong","year":"2008","unstructured":"Lie Fong S, Lugtenburg PJ, Schipper I, Themmen AP, de Jong FH, Sonneveld P, et al. Anti-m\u00fcllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod. 2008;23(3):674\u20138.","journal-title":"Hum Reprod"},{"issue":"1","key":"3323_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.rbmo.2013.07.014","volume":"28","author":"S Senapati","year":"2014","unstructured":"Senapati S, Morse CB, Sammel MD, Kim J, Mersereau JE, Efymow B, Gracia CR. Fertility preservation in patients with haematological disorders: a retrospective cohort study. Reprod Biomed Online. 2014;28(1):92\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"3323_CR33","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","volume":"99","author":"JC Arce","year":"2013","unstructured":"Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril. 2013;99(6):1644\u201353.","journal-title":"Fertil Steril"},{"issue":"2","key":"3323_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/humupd\/dmp036","volume":"16","author":"A La Marca","year":"2010","unstructured":"La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010;16(2):113\u201330.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"3323_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","volume":"93","author":"K Jayaprakasan","year":"2010","unstructured":"Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-M\u00fcllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2010;93(3):855\u201364.","journal-title":"Fertil Steril"},{"key":"3323_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1477-7827-9-115","volume":"9","author":"RK Lee","year":"2011","unstructured":"Lee RK, Wu FS, Lin MH, Lin SY, Hwu YM. The predictability of serum anti-M\u00fcllerian level in IVF\/ICSI outcomes for patients of advanced reproductive age. Reprod Biol Endocrinol. 2011;9:115.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"3323_CR37","doi-asserted-by":"publisher","first-page":"e2014028","DOI":"10.4084\/mjhid.2014.028","volume":"6","author":"E Abruzzese","year":"2014","unstructured":"Abruzzese E, Trawinska MM, Perrotti AP, De Fabritiis P. Tyrosine kinase inhibitors and pregnancy. Mediterr J Hematol Infect Dis. 2014;6(1):e2014028.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"7","key":"3323_CR38","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1200\/JCO.2005.04.6557","volume":"24","author":"P Ault","year":"2006","unstructured":"Ault P, Kantarjian H, O\u2019Brien S, Faderl S, Beran M, Rios MB, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol. 2006;24(7):1204\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3323_CR39","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/jog.14668","volume":"47","author":"T Ogawa","year":"2021","unstructured":"Ogawa T, Ogi M, Hirata S. A case of ovarian stimulation for fertility preservation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after treatment with dasatinib. J Obstet Gynaecol Res. 2021;47(3):1182\u20135.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"3323_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","volume":"53","author":"D Meirow","year":"2010","unstructured":"Meirow D, Biederman H, Anderson RA, Wallace WH. Toxicity of chemotherapy and radiation on female reproduction. Clin Obstet Gynecol. 2010;53(4):727\u201339.","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"3323_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/bmt.2013.211","volume":"49","author":"S Joshi","year":"2014","unstructured":"Joshi S, Savani BN, Chow EJ, Gilleece MH, Halter J, Jacobsohn DA, Pidala J, et al. Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2014;49(4):477\u201384.","journal-title":"Bone Marrow Transplant"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03323-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T16:09:18Z","timestamp":1661011758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03323-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict to disclose regarding this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}